References
Anthony DF, Beattie J, Paul A, Currie S (2007) Interaction of calcium/calmodulin-dependent protein kinase IIδC with sorcin indirectly modulates ryanodine receptor function in cardiac myocytes. J Mol Cell Cardiol 43:492–503
Beyer-Sehlmeyer G, Hiddemann W, WÖrmann B, Bertram J (1999) Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin. Eur J Cancer 35:1735–1742
Brownawell AM, Creutz CE (1997) Calcium-dependent binding of sorcin to the N-terminal domain of synexin (annexin VII). J Biol Chem 272:22182–22190
Chuthapisith S, Bean BE, Cowley G, Eremin JM, Samphao S, Layfield R et al (2009) Annexins in human breast cancer: possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer 45:1274–1281
Chuthapisith S, Layfield R, Kerr ID, Hughes C, Eremin O (2007) Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int J Oncol 30:1545–1551
Colotti G, Zamparelli C, Verzili D, Mella M, Loughrey CM, Smith GL, Chiancone E (2006) The W105G and W99G sorcin mutants demonstrate the role of the D helix in the Ca2+-dependent interaction with annexin VII and the cardiac ryanodine receptor. Biochemistry 45:12519–12529
Deng L, Su T, Leng A, Zhang X, Xu M, Yan L, Gu H, Zhang G (2010) Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer. Med Oncol 27:1102–1108
Fowler MR, Colotti G, Chiancone E, Higuchi Y, Seidler T, Smith GL (2009) Complex modulation of L-type Ca2+ current inactivation by sorcin in isolated rabbit cardiomyocytes. Eur J Physiol 457:1049–1060
Fowler MR, Colotti G, Chiancone E, Smith GL, Fearon IM (2008) Sorcin modulates cardiac L-type Ca2+ current by functional interaction with the α1C subunit in rabbits. Exp Physiol 93:1233–1238
Hall MD, Handley MD, Gottesman MM (2009) Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol Sci 30:546–556
Hansen C, Tarabykina S, la Cour JM, Lollike K, Berchtold MW (2003) The PEF family proteins sorcin and grancalcin interact in vivo and in vitro. FEBS Lett 545:151–154
He Q, Zhang G, Hou D, Leng A, Xu M, Peng J, Liu T (2011) Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp. Oncol Rep 25:237–243
Ilari A, Johnson KA, Nastopoulos V, Verzili D, Zamparelli C, Colotti G, Tsernoglou D, Chiancone E (2002) The crystal structure of the sorcin calcium binding domain provides a model of Ca2+-dependent processes in the full-length protein. J Mol Biol 317:447–458
Jin JH, Hulette C, Wang Y, Zhang T, Pan C, Wadhwa R, Zhang J (2006) Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol Cell Proteomics 5:1193–1204
Kawakami M, Nakamura T, Okamura N, Komoto C, Markova S, Kobayashi H et al (2007) Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells. Biol Pharm Bull 30:1065–1073
Kobayashi T, Yamada Y, Fukao M, Tsutsuura M, Tohse N (2007) Regulation of CaV1.2 Current: interaction with intracellular molecules. J Pharmacol Sci 103:347–353
Koch G, Smith M, Twentyman P, Wright K (1986) Identification of a novel calcium-binding protein (CP22) in multidrug-resistant murine and hamster cells. FEBS Lett 195:275–279
Landriscina M, Laudiero G, Maddalena F, Amoroso MR, Piscazzi A, Cozzolino F, Monti M, Garbi C, Fersini A, Pucci P, Esposito F (2010) Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res 70:6577–6586
Li J, Chen BA, Zhu MS, Gao F, Ding JH, Gao C et al (2008) Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16:65–69
Lollike K, Johnsen AH, Durussel I, Borregaard N, Cox JA (2001) Biochemical characterization of the Penta-EF-hand protein grancalcin and identification of L-plastin as a binding partner. J Biol Chem 276:17762–17769
Maki M, Kitaura Y, Satoh H, Ohkouchi S, Shibata H (2002) Structures, functions and molecular evolution of the penta-EF-hand Ca2+-binding proteins. Biochim Biophys Acta 1600:51–60
Margetis P, Antonelou M, Karababa F, Loutradi A, Margaritis L, Papassideri I (2007) Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations. Blood Cell Mol Dis 38:210–220
Martinsson T, Dahllöf B, Wettergren Y, Leffler H, Levan G (1985) Pleiotropic drug resistance and gene amplification in a SEWA mouse tumor cell line. Complex relations revealed by drug uptake data, and lipid and protein analysis. Exp Cell Res 158:382–394
Meyers MB, Biedler JL (1981) Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res Commun 99:228–235
Meyers MB, Spengler BA, Chang TD, Melera PW, Biedler JL (1985) Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistant Chinese hamster, mouse, and human cells. J Cell Biol 100:588–597
Okamoto Y, Chaves A, Chen J, Kelley R, Jones K, Weed HG et al (2001) Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. Am J Pathol 159:639–650
Pack-Chung E, Meyers MB, Pettingell WP, Moir RD, Brownawell AM, Cheng I et al (2000) Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor. J Biol Chem 275:14440–14445
Parekh HK, Deng HB, Choudhary K, Houser SR, Simpkins H (2002) Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol 63:1149–1158
Qi J, Liu N, Zhou Y, Tan Y, Cheng Y, Yang C, Zhu Z, Xiong D (2006) Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Biochem Biophys Res Commun 349:303–309
Qu Y, Yang Y, Liu B, Xiao W (2010) Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Med Oncol 27:1303–1308
Rueda A, Song M, Toro L, Stefani E, Valdivia HH (2006) Sorcin modulation of Ca2+ sparks in rat vascular smooth muscle cells. J Physiol 576:887–901
Salzer U, Hinterdorfer P, Hunger U, Borken C, Prohaska R (2002) Ca(++)-dependent vesicle release from erythrocytes lipid rafts, synexin (annexin VII), and sorcin. Blood 99:2569–2577
Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234
Takeda T, Asahi M, Yamaguchi O, Hikoso S, Nakayama H, Kusakari Y et al (2005) Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling. FASEB J 19:2069–2071
Tan Y, Li G, Zhao C, Wang J, Zhao H, Xue Y, Han M, Yang C (2003) Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leukemia Res 27:125–131
Tripodi D, Quéméner S, Renaudin K, Ferron C, Malard O, Guisle-Marsollier I et al (2009) Gene expression profiling in sinonasal adenocarcinoma. BMC Med Genomics 2:65
Twentyman PR, Reeve JG, Koch G, Wright KA (1990) Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin). Br J Cancer 62:89–95
Valdivia HH (1998) Modulation of intracellular Ca2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors. Trends Pharmacol Sci 19:479–482
Valkova N, Yunis R, Mak SK, Kang K, Kültz D (2005) Nek8 mutation causes overexpression of aalectin-1, sorcin, and vimentin and accumulation of the major urinary protein in renal cysts of jck Mice. Mol Cell Proteomics 4:1009–1018
Van der Blick AM, Baas F, Van der Velde-Koerts T, Biedler JL, Meyers MB, Ozols RF et al (1988) Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res 48:5927–5932
Van der Bliek AM, Meyers MB, Biedler JL, Hes E, Borst P (1986) A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain. EMBO J 5:3201–3208
Verzili D, Zamparelli C, Mattei B, Noegel AA, Chiancone E (2000) The sorcin-annexin VII calcium-dependent interaction requires the sorcin N-terminal domain. FEBS Lett 471:197–200
Wang SL, Tam MF, Ho YS, Pai SH, Kao MC (1995) Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant HOB1 lymphoma cells. Biochim Biophys Acta 1260:285–293
Werner CJ, Heyny-von Haussen R, Mall G, Wolf S (2008) Proteome analysis of human substantia nigra in Parkinson’s disease. Proteome Sci 6:8
Wilkinson DK, Turner EJ, Parkin ET, Garner AE, Harrison PJ, Crawford M, Stewart GW, Hooper NM (2008) Membrane raft actin deficiency and altered Ca2+-induced vesiculation in stomatin-deficient overhydrated hereditary stomatocytosis. Biochim Biophys Acta 1778:125–132
Witkowski JM, Miller RA (1999) Calcium signal abnormalities in murine T lymphocytes that express the multidrug transporter P-glycoprotein. Mech Ageing Dev 107:165–180
Xie XL, Dwyer MD, Swenson L, Parker MH, Botfield MC (2001) Crystal structure of calcium-free human sorcin: a member of the penta-EF-hand protein family. Protein Sci 10:2419–2425
Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ (2008) A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem 104:1010–1021
Yang YX, Xiao ZQ, Chen ZC, Zhang GY, Yi H, Zhang PF, Li JL, Zhu G (2006) Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics 6:2009–2021
Zamparelli C, Ilari A, Verzili D, Vecchini P, Chiancone E (1997) Calcium- and pH-linked oligomerization of sorcin causing translocation from cytosol to membranes. FEBS Lett 409:1–6
Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C, Zhu Z, Xiong D (2006) Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leukemia Res 30:469–476
Acknowledgments
This work was funded by the Natural Science Foundation of China Grants (30973548) and Shandong Province Outstanding Young Scientists Research Award Fund Project (BS2010SW020).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zheng, BB., Zhang, P., Jia, WW. et al. Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer. J Physiol Biochem 68, 281–287 (2012). https://doi.org/10.1007/s13105-011-0140-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-011-0140-0